Literature DB >> 25717094

Tuberculosis vaccines: time for a global strategy.

Stefan H E Kaufmann1, Thomas G Evans2, Willem A Hanekom3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25717094     DOI： 10.1126/scitranslmed.aaa4730

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  26 in total

1.  Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.

Authors:  Chuang Meng; Xiaoyan Wang; Zhengzhong Xu; Maozhi Hu; Jiaying Liu; Zhiming Pan; Xiang Chen; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-05       Impact factor: 2.416

Review 2.  Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Authors:  Robert L Hunter
Journal:  Tuberculosis (Edinb)       Date:  2016-01-02       Impact factor: 3.131

Review 3.  The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.

Authors:  Robert Hunter; Jeffrey Actor
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

Review 4.  Recent advances in the development of vaccines for tuberculosis.

Authors:  Mohamed Jawed Ahsan
Journal:  Ther Adv Vaccines       Date:  2015-05

5.  Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

Authors:  Marco Schito; Giovanni Battista Migliori; Helen A Fletcher; Ruth McNerney; Rosella Centis; Lia D'Ambrosio; Matthew Bates; Gibson Kibiki; Nathan Kapata; Tumena Corrah; Jamshed Bomanji; Cris Vilaplana; Daniel Johnson; Peter Mwaba; Markus Maeurer; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

6.  ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.

Authors:  Andreas Kupz; Ulrike Zedler; Manuela Stäber; Carolina Perdomo; Anca Dorhoi; Roland Brosch; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

7.  Identification of Mycobacterial Ribosomal Proteins as Targets for CD4+ T Cells That Enhance Protective Immunity in Tuberculosis.

Authors:  Steven C Kennedy; Alison J Johnson; Sushma Bharrhan; Cecilia S Lindestam Arlehamn; Jiayong Xu; Scott J Garforth; John Chan; William R Jacobs; Alessandro Sette; Steven C Almo; Steven A Porcelli
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

Review 8.  Research and development of new tuberculosis vaccines: a review.

Authors:  Lewis K Schrager; Rebecca C Harris; Johan Vekemans
Journal:  F1000Res       Date:  2018-11-01

9.  Reasons for optimism in the search for new vaccines for tuberculosis.

Authors:  T G Evans
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

10.  Lactococcus lactis FNBPA+ (pValac:e6ag85a) Induces Cellular and Humoral Immune Responses After Oral Immunization of Mice.

Authors:  Camila Prósperi de Castro; Bianca Mendes Souza; Pamela Mancha-Agresti; Vanessa Bastos Pereira; Meritxell Zurita-Turk; Tatiane Melo Preisser; Vanessa Pecini da Cunha; Janete Soares Coelho Dos Santos; Sophie Yvette Leclercq; Vasco Azevedo; Anderson Miyoshi
Journal:  Front Microbiol       Date:  2021-05-20       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.